USG PREECLAMPSIA SCREENING (₹ 2500)     Book An Appointment

Diagnopein USG PREECLAMPSIA SCREENING Centre in Karad

Diagnopein USG PREECLAMPSIA SCREENING Centre in Karad

USG Preeclampsia Screening is a vital ultrasound-based test performed during early pregnancy to assess the risk of developing preeclampsia—a condition characterized by high blood pressure and potential organ complications. This screening typically takes place between 11 to 14 weeks of pregnancy. It helps in detecting early signs of risk, allowing doctors to monitor and manage the mother’s health proactively.

Preeclampsia, if left undiagnosed, can cause serious complications such as reduced blood flow to the placenta, fetal growth restrictions, and in severe cases, life-threatening pregnancy outcomes. USG Preeclampsia Screening provides a clear view of maternal and fetal well-being, enabling timely prevention through proper medication and care.

USG PREECLAMPSIA SCREENING Centre in Karad    Book Appointment

Why USG Preeclampsia Screening Is Important

The main reason for performing USG Preeclampsia Screening is to detect early indicators that increase the risk of high blood pressure and preeclampsia during pregnancy. This test helps healthcare providers take preventative actions such as blood pressure management, diet modification, and medications like low-dose aspirin for high-risk mothers.

Early detection is crucial because preeclampsia not only endangers maternal health but can also affect the baby’s growth and oxygen supply. Preeclampsia ultrasound screening gives expectant mothers reassurance and helps consultative gynecologists to plan personalized antenatal care based on findings.

Key benefits include:

  1. Identifying mothers at risk for developing hypertension during pregnancy.

  2. Reducing complications through early medical management.

  3. Protecting maternal and fetal health by ensuring timely intervention.

  4. Improving pregnancy outcomes through close monitoring and follow-ups.


Benefits of USG Preeclampsia Screening

There are multiple medical and emotional benefits of undergoing USG Preeclampsia Screening during pregnancy:

  1. Early diagnosis: The test recognizes potential risks before symptoms appear.

  2. Preventive care: Timely administration of preventive treatments reduces complications.

  3. Safe and painless: The procedure is non-invasive and entirely safe for both mother and baby.

  4. Improved fetal growth: Ensures proper oxygen and nutrient supply to the baby by maintaining normal placental function.

  5. Customized antenatal plan: Based on the results, doctors can develop a personalized check-up plan to reduce pregnancy risks.

Preeclampsia is one of the most common causes of maternal complications, and by detecting it early through ultrasound-based preeclampsia screening, mothers can ensure a smoother pregnancy journey.


How USG Preeclampsia Screening Test Is Done

The USG Preeclampsia Screening test is typically combined with the first-trimester ultrasound. Using advanced ultrasound technology, the sonographer evaluates the uterine arteries’ blood flow using Doppler ultrasound. Along with the scan, maternal blood pressure readings and biochemical markers such as PlGF (Placental Growth Factor) and PAPP-A (Pregnancy-Associated Plasma Protein A) are assessed.

Step-by-step process:

  1. The patient lies comfortably as a sonographer applies gel on the lower abdomen.

  2. Transabdominal ultrasound is used to visualize blood flow in the uterine arteries.

  3. Doppler readings measure resistance indices to evaluate the likelihood of preeclampsia.

  4. Results are analyzed with maternal data, blood pressure, and biochemical parameters.

  5. The obstetrician interprets results and provides a risk report with suggested care guidelines.

This scan is quick, taking about 20–30 minutes, and does not require special preparation. USG Preeclampsia Doppler Screening is a part of standard prenatal diagnostics in modern obstetric care.


Key Parameters Evaluated in USG Preeclampsia Screening

During the USG Preeclampsia Screening, several clinical and sonographic parameters are analyzed to determine the patient's risk level:

  1. Uterine artery Pulsatility Index (PI) via Preeclampsia Doppler ultrasound

  2. Maternal mean arterial pressure (MAP)

  3. Serum Placental Growth Factor (PlGF)

  4. Pregnancy-Associated Plasma Protein A (PAPP-A)

  5. Maternal age, BMI, parity, and medical history

The final report categorizes risk levels as low, moderate, or high, allowing the doctor to advise appropriate interventions such as nutritional supplements and lifestyle guidance to reduce the risk.

Diagnopein USG PREECLAMPSIA SCREENING Treatement Cost     Book Appointment

Talk to Our Radiologist.

  I HereBy Consent to receive calls/messagess from Diagnopein Radiologist and its partners and override DND settings